Announcements Trials

Browse Landscape

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 71 Neoplasms 70 Lung Neoplasms 29 Prostatic Neoplasms 26 Head and Neck Neoplasms 22 Colorectal Neoplasms 19 Uterine Cervical Neoplasms 17 Ovarian Neoplasms 13 Neoplasm Metastasis 13 Motor Activity 13 Fatigue 11 Endometrial Neoplasms 11 Colonic Neoplasms 11 Brain Neoplasms 11 Pain 10 Carcinoma, Non-Small-Cell Lung 10 Multiple Myeloma 9 Melanoma 9 Rectal Neoplasms 8 Leukemia 8 Gastrointestinal Neoplasms 8 Smoking Cessation 7 Pancreatic Neoplasms 7 Lymphoma 7 Depression 7 cyclopia sequence 6 Esophageal Neoplasms 6 Carcinoma, Renal Cell 6 Advanced Cancer 6 Uterine Neoplasms 5

Interventions

pembrolizumab 25 Gemcitabine 21 Nivolumab 17 Cisplatin 17 atezolizumab 14 Carboplatin 11 avelumab 9 vinflunine 7 Ipilimumab 7 Paclitaxel 6 Docetaxel 5 enfortumab vedotin 4 cabazitaxel 4 Pemetrexed 4 Mitomycin 4 cabozantinib 3 Taxes 3 Rogaratinib 3 Magnetic Resonance Spectroscopy 3 Injections 3 Albumin-Bound Paclitaxel 3 tremelimumab 2 sacituzumab govitecan 2 pemigatinib 2 niraparib 2 lenvatinib 2 bempegaldesleukin 2 apatorsen 2 XRP6258 2 Vitamin D 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Transitional Cell × Surveys and Questionnaires × Clear all

NCT04566029 2025-12-10

AMI

Centre Hospitalier Universitaire de Nīmes

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡